Palantir Jumps After ‘Otherworldly Demand Lifts Outlook

4 Aug 2026 · 22 min · 14 chapters

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

The episode is a Bloomberg Intelligence market wrap focused on earnings and AI-driven themes. Topic 1: Palantir’s stock jump after it boosted its four-year revenue and income outlook, citing “otherworldly” commercial demand for its data analytics tools.

Guest

Mandeep Singh (Bloomberg Intelligence tech analyst) explains Palantir’s government/defense big-data dashboards and its pivot to LLMs; key claim is growth acceleration (13 consecutive quarters) but fragility from a concentrated customer base (~1,000 customers vs Microsoft/Snowflake/Databricks).

Notable examples

Forward Deployed Engineers (FDEs) and competition concerns from OpenAI/Anthropic/hyperscalers; open-weight support as a signal. Topic 2: McDonald’s U.S. results—value strategy missteps (BOGOs removed, fewer app discounts, “10 items for $3” underperformed), plus leadership change (Joe Erlinger out; Sky Anderson COO).

Guest

Michael Halen (senior restaurant/food service analyst). Topic 3: Caterpillar blowout quarter—AI PowerGen, record backlog >$72B; guest Christopher Cialino (machinery analyst). Topic 4: Pfizer and Merck—“patent cliff” narrative; guest Sam Fazelli (healthcare/defense/industrials/autos director). Topic 5: Tech minute on airline AI seat pricing; plus healthcare/airline/AI ads.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Chapters

Tap a time to open that second in VO

Analyzing Palantir's Earnings

0:15 to 1:09

Discussion on Palantir's recent earnings and growth amid AI advancements.

“When you're running a business, the best days are the ones where priorities stay on track.”

Analyzing Palantir's Earnings

1:13 to 1:42

Discussion on Palantir's recent earnings and growth amid AI advancements.

“Everyone's talking about how AI is transforming work, especially in sales.”

Analyzing Palantir's Earnings

2:10 to 4:02

Discussion on Palantir's recent earnings and growth amid AI advancements.

“but the shares jumped by the most in almost 16 months after the company boosted four year revenue and income forecast as described and described commercial demand for its data analytics tools as, quote, otherworldly.”

Discussing Competition for Palantir

4:02 to 5:36

Exploration of the competitive landscape Palantir faces from rivals.

“And that's the real risk for me when I look at the growth trajectory next couple of years.”

Implications of AI and Compute Power

5:36 to 6:44

Insights on how AI and compute capabilities are evolving in tech.

“And that's where the higher valuation kind of creates a risk.”

Challenges Facing McDonald's

6:44 to 7:42

Analysis of McDonald's recent sales struggles and strategic missteps.

“And just to be clear, we never used the term compute before, did we?”

Leadership Changes at McDonald's

7:42 to 14:00

Discussion on leadership changes at McDonald's and their potential impact.

“Review the disclosures and disclaimers at SIBO.com slash US underscore disclaimers.”

Impact of Cyclospora on Taco Bell

14:00 to 16:51

Learn about the cyclospora outbreak affecting Taco Bell and its implications.

“I mean, Erlinger did a great job, you know.”

The Afternoon Rush: Fast Food Strategies

18:07 to 19:36

Explore how fast food chains like McDonald's and Starbucks are boosting sales during slow hours.

“Everyone's talking about how AI is transforming work, especially in sales.”

Caterpillar's Earnings and Industry Trends

19:45 to 22:58

Caterpillar's impressive earnings report and its position in the machinery sector.

“Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App.”
Show all 14 chapters

The Future of Pharma: Pfizer and Merck

22:58 to 28:00

Discussing the challenges faced by Pfizer and Merck due to patent expirations.

“What other companies are kind of getting some of the business that Caterpillar can't take on?”

Pharmaceutical Pipeline Challenges

28:00 to 30:00

Explore the challenges faced by pharmaceutical companies in managing their drug pipelines and patent expirations.

“exclusivity then they don't drop the price that much but in the end pretty much the business goes away, which is great because that's what pharma companies should do.”

COVID-19 Vaccine Demand Trends

30:00 to 32:32

Discussion on the current state of COVID-19 vaccine demand and its implications for companies like BioNTech.

“The thing is heading for$40 billion of sales because it turned into a pipeline of product.”

COVID-19 Vaccine Demand Trends

32:36 to 33:28

Discussion on the current state of COVID-19 vaccine demand and its implications for companies like BioNTech.

“Start your free trial at adio.com slash iHeart.”
Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:00Looking for more investing options? Meet SIBO, the exchange that pioneered options trading. With exclusive trading products like VIX and SPX options, SIBO can help you trade in any market environment. There are risks associated with SIBO company products. Review the disclosures and disclaimers at SIBO.com slash US underscore disclaimers. When you're running a business, the best days are the ones where priorities stay on track. For midsize and large companies, that isn't always easy. Risk can touch multiple parts of an organization at the same time, often in ways that aren't immediately obvious.

0:28It might involve property, liability, or cyber. It could stem from regulatory requirements or challenges tied to a specific industry or the scale of an operation. At that level, managing risk becomes an ongoing discipline, not a one-time decision. At the Hartford, the focus is on helping businesses manage risk before it turns into something more disruptive. That means working with companies to identify where they're exposed, decide what matters most, and put practical standards in place so risk is managed as part of day-to-day operations. And when losses do happen, the Hartford can pair that risk-control work with insurance coverage grounded in underwriting, risk engineering, and claims experience developed over time.

1:09Learn more at thehartford.com slash risk mitigation. Everyone's talking about how AI is transforming work, especially in sales. While the landscape shifts, one thing remains the same, the thrill of closing a deal. Whether it's a gong or a confetti machine, every team has its celebration rituals. Adio is designed for that moment. It's the agentic CRM that turns customer signals into actionable insights, helping you close deals faster with revenue agents and automations working around the clock. You'll have everything you need to scale your go-to market efforts. Elevate your wins with Adio. Start your free trial at adio.com slash iHeart.

1:47Scarlet Fu:Bloomberg Audio Studios. Podcasts. Radio. News. You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App. Listen on demand wherever you get your podcasts or watch us live on YouTube. Again, I'm just looking. I'm not I don't really know Palantir technologies that well, but the shares jumped by the most in almost 16 months after the company boosted four year revenue and income forecast as described and described commercial demand for its data analytics tools as, quote, otherworldly. I don't know.

2:24I know Mandeep Singh knows. He covers all this tech stuff for Bloomberg Intelligence. Mandeep, can you just briefly describe what Palantir is and what you took away from their earnings last night? I mean, this is a company pre-AI, before LLMs came to the scene, and they have done a lot of customized work for government entities, large defense companies where it helps make sense of big data. Basically, it goes back to that big data days where if you're dealing with large amounts of data, they can help you create a pretty dashboard that can, you know, give you the insights from unstructured data.

3:05Now, with all the LLMs coming to the scene, they clearly have made a pivot towards incorporating LLMs as part of the solution. And what we have seen is accelerating growth over the last 13 quarters. So this is the 13th consecutive quarter of top line acceleration. And, you know, 93 % growth is very impressive for a software company. But when I look at, you know, the customer base, we're talking about housing customers. So it's very high ASPs, very high monetization at their customer base, which, like I said, half of this is coming from the government. And so from that perspective, a typical enterprise company like Microsoft has got over 100 ,000 customers.

3:54Even a Snowflake or Databricks has got 20 ,000 plus customers. Palantir is just catering to 1 ,000 customers. And that's the real risk for me when I look at the growth trajectory next couple of years.

4:08Scarlet Fu:So you're saying that's a source of fragility rather than a source of strength for Palantir. What could disrupt that? I mean, does that make Palantir more vulnerable to a competitor coming in? Yeah. I mean, the fact that the CEO has been so vocal about Enthropic and OpenAI and how suddenly out of all the companies, Palantir is supporting open source. I mean, this is a company that has benefited greatly from selling a proprietary solution, and now it's coming out and being so vocal about open source support. So that, I think, gives you an indication that they do see the competition coming from the likes of OpenAI and Tropic, as well as the hyperscalers.

4:49I mean, what Palantir did really well was they had this concept called FDE, Forward Deployed Engineers, that were part of their employee base. So when you're installing a solution, the FDEs actually help you get there faster. And now all of these companies, whether it's Microsoft, Amazon, they have this FDE team that they are using to deploy their own LLM. So I think competition-wise, I feel there will be more competition from Palantir, and they can see that, which is why they are being so vocal with open-weight support. And I mean, the growth trajectory, they guided to increase top line growth.

5:31So it was a beat and raise quarter. But to my mind, the growth rates will normalize. And that's where the higher valuation kind of creates a risk. You mentioned Anthropic. Yeah. Because we're looking for a potential IPO maybe later this year. Bloomberg News has got a story that Anthropic has struck a$10 billion deal for computing capacity from a months old infrastructure startup. Okay. making the cloud maker's latest effort to keep pace with demand for its products. What is that all about? I mean, right now, Entropic is just getting compute from wherever they can, whether it's SpaceX or Meta or, you know, these, in this case, this small company, Bitcoin mining company that has compute.

6:13Hold on, hold on. A Bitcoin mining company is now providing compute for an AI play. Yeah, because at the end, it's a data center.

6:22Scarlet Fu:That's the dream for these Bitcoin mining companies. once they make the transition. I mean, compute is agnostic of where, you know, that data center is set up, what purpose it was used for in the past. It doesn't matter. Compute is unique processing capability with life power connected to a grid. That's all you care about. And just to be clear, we never used the term compute before, did we? Not in that way. We used it as a verb. Yes, we never said it as a noun. Yeah, well... See, I just want to make sure. I'm calling these tech people out on some of this stuff. Well, they make up a lot of words.

6:57They do. But I need more compute. Is that what you... That's what all these OOMs need. If you listen to any conference they are on, they'll tell you the world needs 10 times, 50 times more compute than currently available.

7:13Scarlet Fu:Stay with us. More from Bloomberg Intelligence coming up after this. When your options are limited, so are your opportunities. At SIBO, the global exchange that pioneered options trading, we offer more ways to move with the market. From VIX and SPX options to global market data solutions, SIBO helps investors diversify, manage risk, and stay ahead of whatever the market does next. SIBO. Life is better with options. Your investments could be too. There are risks associated with SIBO company products. Review the disclosures and disclaimers at SIBO.com slash US underscore disclaimers. This is the Bloomberg Tech Minute brought to you by ChatGPT.

7:53Scarlet Fu:Now with ChatGPT work. I'm Carol Masser. Globetrotters hunting for airfare bargains are in for a rude awakening as the days of stumbling across a cheap seat on a popular flight could soon disappear. Bloomberg's Juan Ha reports that airlines from Delta to Virgin Atlantic are adopting artificial intelligence to change seat prices more quickly by weighing dozens of variables in real time, helping capture more revenue while shrinking pricing gaps that once allowed travelers to find bargain fares. Machine learning models can more accurately forecast demand by analyzing historical booking patterns, seat inventory, and seasonal trends, while also continuously tracking competitors' fares and capacity changes to update prices in near real time.

8:36Scarlet Fu:The technology could lead to higher fares on busy routes as airlines pack flights closer to capacity, but may also result in lower fares on off-peak and lower demand routes. That's the Bloomberg Tech Minute brought to you by ChatGPT. Put ChatGPT to work on your most ambitious ideas and projects. Get started at ChatGPT.com today by selecting work mode available on plus and pro plans. Everyone's talking about how AI is transforming work, especially in sales. While the landscape shifts, one thing remains the same, the thrill of closing a deal. Whether it's a gong or a confetti machine, every team has its celebration rituals.

9:16Adio is designed for that moment. It's the agentic CRM that turns customer signals into actionable insights, helping you close deals faster with revenue agents and automations working around the clock. You'll have everything you need to scale your go-to market efforts. Elevate your wins with Adio. Start your free trial at adio.com slash iHeart.

9:37Scarlet Fu:You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern On Apple CarPlay and Android Auto with the Bloomberg Business app. Listen on demand wherever you get your podcasts or watch us live on YouTube. It is, of course, the thick of earnings season. And this morning we got indication from McDonald's that U.S. sales perhaps not living up to what was promised or what was expected. Comparable sales in the U.S. coming in a little bit lighter than anticipated. Michael Halen is our senior restaurant and food service analyst and joins us in studio. So, Michael, I thought McDonald's was one of the companies that would benefit from consumers seeking value, seeking perhaps lower costs and more convenient food options.

10:21Scarlet Fu:And it certainly looked that way in quarters past. What happened this last quarter? Yeah, so last year they did a good job of reestablishing themselves as the value leader. They were also lapping really weak comps due to E. coli. And so as a result, they had very strong results last year. This year, we didn't think it was a great idea to just try to lap these really strong comps with just value, A. B, they kind of screwed up the whole value thing. They pulled BOGOs, buy one, get one offers. They took away a lot of discounts on the app, which their lower income consumers use all the time. And they pushed a 10 items for$3 menu that kind of fell flat.

11:08And so all of those changes that happened actually created an increase of prices for their consumers. So that paired with a tough year-over-year comparison showed up in their results today. The company is embarking on a multi-year plan to become more than just a fast, cheap meal, with the aim of being the first choice for family outings and other occasions. How are they going to do that? You know, listen, we'll probably see more tie-ins. You know, last year was the Minecraft meal that was absolutely a monster for them globally, right? So they're going to have to use some more tie-ins. You know, it's going to be tough.

11:51You know, I think what we're seeing is McDonald's kind of taking some of these family occasions away from McDonald's this year. Burger King has remodeled their restaurants, improved the quality of the food, and really done a nice job of building back sales over the last few quarters. And I think McDonald's is feeling it, and that's why they're kind of talking about that segment, because it seems like they may be losing some share there. I think what the real drivers of this will be are beverages. I think beverages is a very good opportunity for them to grow sales in the afternoon, day part. I think they can take sales away from Sonic, who is a big competitor in the beverage space that does a nice job in that 2 to 4 p.m.

12:39lull where the restaurants are staffed. And so they're primed to do more business. It's very incremental sales in that day part. They're going to do some more training, some retraining in the fourth quarter to help boost their operations. I think they're gonna they're not gonna do what they did this quarter Which was just throw too many different marketing initiatives against the wall, right? You have to be more disciplined in today's market because you know These windows Everyone's marketing and everyone's putting out LTOs and new food items and discounts out there all the time Because the low-income consumer is struggling and so what we're seeing now is that promotions are only giving you these chains a lift for one or two weeks.

13:25And then it fades. And then it fades. And so, you know, if you're constantly marketing something new every couple of weeks, you know, it gets confusing for the consumer, confusing for the employees. It just kind of makes a mess of things which happened this quarter.

13:42Scarlet Fu:Yeah, it just becomes noise in the background. A lot of analysts are saying that the results are kind of the secondary story. The bigger story here is a change in McDonald's USA leadership. Joe Erlinger is out and Sky Anderson, who was the COO, comes in. Do you see this changing things dramatically for McDonald's? I don't think so. I mean, Erlinger did a great job, you know. So, you know, that may be viewed as a loss by some. But Sky Anderson has been there for a long time. she's worked very closely with joe and the u.s team uh in charge of operations so um you know she has a long track strong track record at mcdonald's so so i don't expect too much of a change there cyclo what is it again cyclospora yeah what is that uh it's a parasite that um causes you know very very bad diarrhea and so this is something that's impacting the lettuce yes yes this is impacting lettuce there was a pretty big recall of taylor farms is a big and taco bell getting caught up in it and taco bell got caught up there was some news today that wasn't a good look for them right so that it was you know some somebody got a hold of some emails that showed they knew about this this outbreak maybe a couple weeks before they let their consumers know and so uh yeah not a good look for them also there was a couple of deaths i think they were people that were had health issues prior to cyclospora but that's uncommon for cyclospora deaths right that's more of like an e coli thing um so not great for yum brands but you know at the same time they just divested pizza hut people are going to forget about the cyclospora outbreak and you know this company is set up for much much stronger top and bottom line growth over the next 12 months because of you know they got rid of that yolk on its neck so So they just have to get through this period, in other words, you know, with all the bad news and figuring out a solution to this.

15:45Scarlet Fu:I want to go back to something you said earlier, Michael, about how McDonald's is trying to get more people into its stores in the afternoon hours, you know, like with drinks. I think about Starbucks and how it's trying to get more people into its stores through food items. So everyone's just trying to get away to get consumers to come in around, what, 2 to 4 p.m.? That's the lull. And that's like the time of day they've targeted. And if you sell food, then you want to provide drinks. If you sell drinks, then you want to provide food. What did people do? What did companies do with that time slot before this, before this focused attention?

16:19Scarlet Fu:They just kind of gave up on it? No, I mean, you know, it makes a lot of sense because your stores are staffed, right? You have people in the stores, but you don't have a lot of customers coming in. So any of those sales that you can bring in in those types of time periods, they call them the shoulder periods, are very high margin. It's basically all incremental. Samantha writes in and says they need to offer happy hours. That's a concept that works in the bar business. Why not in like a McDonald's or Starbucks? Yeah. Stay with us. More from Bloomberg Intelligence coming up after this.

16:57Scarlet Fu:This is the Bloomberg Tech Minute brought to you by ChatGPT. Now with ChatGPT work. I'm Carol Masser. Globe trotters hunting for airfare bargains are in for a rude awakening, as the days of stumbling across a cheap seat on a popular flight could soon disappear. Bloomberg's Juan Ha reports that airlines from Delta to Virgin Atlantic are adopting artificial intelligence to change seat prices more quickly by weighing dozens of variables in real time, helping capture more revenue while shrinking pricing gaps that once allowed travelers to find bargain fares. Machine learning models can more accurately forecast demand by analyzing historical booking patterns, seed inventory, and seasonal trends, while also continuously tracking competitors' fares and capacity changes to update prices in near real time.

17:44Scarlet Fu:The technology could lead to higher fares on busy routes as airlines pack flights closer to capacity, but may also result in lower fares on off-peak and lower-demand routes. That's the Bloomberg Tech Minute, brought to you by ChatGPT. Put ChatGPT to work on your most ambitious ideas and projects. Get started at ChachiPT.com today by selecting Work Mode. Available on Plus and Pro Plans. Everyone's talking about how AI is transforming work, especially in sales. While the landscape shifts, one thing remains the same. The thrill of closing a deal. Whether it's a gong or a confetti machine, every team has its celebration rituals.

18:23Adio is designed for that moment. It's the agentic CRM that turns customer signals into actionable insights, helping you close deals faster with revenue agents and automations working around the clock. You'll have everything you need to scale your go-to market efforts. Elevate your wins with Adio. Start your free trial at adio.com slash iHeart.

18:48Scarlet Fu:Every sale comes down to a single second. The one between buy now and maybe later. PayPal is built to help your business win that moment. with a checkout experience that feels certain, reliable, and familiar. With a global two-sided network and hundreds of millions of buyers who already know us. All to keep you in control however buying happens next. New markets, new AI-powered selling services. A whole new agentic era where you decide how your business will show up and stand up. PayPal is built to help your business come out ahead. We're built for payments, built for growth, built for Agendic.

19:32Scarlet Fu:PayPal Open, built for all business. Visit PayPalOpen.com to get started. That's PayPalOpen.com. You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App. Listen on demand wherever you get your podcasts. or watch us live on YouTube. We also have earnings out from Caterpillar, which normally, you know, it's a maker of earth-moving machines, bulldozers, the like, but now it's become an AI play, not just in a construction and mining equipment company. It's so much more. Christopher Cialino is our senior U.S.

20:15Scarlet Fu:machinery analyst here at Bloomberg Intelligence, and he joins us now with more on these results, which some people have called blowout results, especially the upside to Wall Street estimates for a second quarter profit. Chris, give us a quick read here on Caterpillar's latest results. Yeah, it's hard to refute those comments. It was really a monster quarter. You had, again, pretty lofty expectations heading into the print. You had a really convincing beat and raise, better than expected sales and margins across all three businesses. So it's not just the AI PowerGen business. And actually, I would say one of the more encouraging takeaways from this print was the performance in their construction business, which really suggests that this recovery is broadening out, where you have a lot of this cyclical tailwind starting to kick in and kind of enhance what we're seeing on the secular side with the data center build out.

21:12Orders, again, very strong in the quarter, pushed backlog to another record level. We're north of$72 billion on the backlog. They're already starting to take some orders out to 2030. So above average production visibility. There's really a lot to like in this report. The question now becomes, is this as good as it gets? So we shall see from here. So, Chris, as I understand your coverage of machinery and, you know, the deers of the world, the cats of the world, I mean, I think that is classic cyclical stuff. But these stocks are trading 35 times earnings. I mean, you're like a growth stock industry now.

21:49What's going on with your industry? Is it still cyclical? It's hard to wrap your head around some of the valuations in the space. So we had Caterpillar, if you look over to last year, it's really traded in line with a lot of the AI and hyperscaler names in terms of just the moves and the trajectory. It's been one of the top performers in the industrials world because of that data center exposure in their power generation business. At the end of the day, I still believe this is still a cyclical company. They had just been, you know, fortunately positioned to capitalize on some of this build out with their large engines and reciprocating natural gas engines, which initially were used more for backup power on the data centers but are becoming increasingly used in prime power applications.

22:37But this is more than just a data center play. You're just beginning to see, I think, the fruits of that in terms of the construction and mining recovery, which we think have some legs into 27 and 28.

22:49Scarlet Fu:You know, if Caterpillar has more demand than it knows what to do with and that power and energy unit has grown to be the largest for Caterpillar by sales, For the stuff that it can't take on, who benefits? What other companies are kind of getting some of the business that Caterpillar can't take on? Right. So it's a race to add capacity at this point. Caterpillar is increasing their large engine capacity by 3x through the end of the decade. Turbines by two and a half times through the end of the decade. Cummins, another one of their competitors. They're also significantly increasing their capacity.

23:25Really, it's just a matter of who has product availability as to who's getting some of these contracts right now. The industry really can't add capacity fast enough. That is one of the overarching concerns now where we're adding too much capacity. But right now, I mean, from all indications from this report, it doesn't seem like there's any signs of that slowing down. And in fact, some of their lead times have actually extended this quarter. Like I mentioned, some of their customers are already taking orders out to 2030, which, you know, highly unusual for them at this point.

23:58Scarlet Fu:Stay with us. More from Bloomberg Intelligence coming up after this.

24:04Scarlet Fu:This is the Bloomberg Tech Minute brought to you by ChatGPT. Now with ChatGPT work. I'm Carol Masser. Globetrotters hunting for airfare bargains are in for a rude awakening as the days of stumbling across a cheap seat on a popular flight could soon disappear. Bloomberg's Wan Ha reports that airlines from Delta to Virgin Atlantic are adopting artificial intelligence to change seat prices more quickly by weighing dozens of variables in real time, helping capture more revenue while shrinking pricing gaps that once allowed travelers to find bargain fares. Machine learning models can more accurately forecast demand by analyzing historical booking patterns, seat inventory, and seasonal trends, while also continuously tracking competitors' fares and capacity changes to update prices in near real time.

24:51Scarlet Fu:The technology could lead to higher fares on busy routes as airlines pack flights closer to capacity, but may also result in lower fares on off-peak and lower-demand routes. That's the Bloomberg Tech Minute brought to you by ChatGPT. Put ChatGPT to work on your most ambitious ideas and projects. Get started at ChatGPT.com today by selecting Work Mode. available on Plus and Pro Plans.

Read the full transcript

25:44go-to market efforts. Elevate your wins with Adio. Start your free trial at adio.com slash iHeart.

25:55Scarlet Fu:Every sale comes down to a single second. The one between buy now and maybe later. PayPal is built to help your business win that moment with a checkout experience that feels certain, reliable, and familiar. With a global two-sided network and hundreds of millions of buyers who already know us. All to keep you in control however buying happens next. New markets, new AI-powered selling services. A whole new agentic era where you decide how your business will show up and stand up. PayPal is built to help your business come out ahead. We're built for payments, built for growth, built for agentic.

26:40PayPal open, built for all business.

26:44Scarlet Fu:Visit paypalopen.com to get started. That's paypalopen.com. You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App. Listen on demand wherever you get your podcasts or watch us live on YouTube. All right, let's go to the healthcare sector. I'm not sure that those stocks are trading those kinds of multiples. Let's bring in Sam Fazelli, who knows a thing or two about the health care sector. He is our director of research covering health care, defense, industrials and autos. And he joins us right now from London.

27:22Scarlet Fu:So, Sam, Pfizer and Merck both coming out with the results. What is the narrative here for these two big pharma companies? Yeah, Scarlett, so the story here really is that you've got two companies both heading and facing some significant patent expiries, which means some of the big drugs are going to go generic and therefore they're going to access but things like any quest that fires themselves are going to fall off a cliff literally and they do call it a bad cliff too um so within six months and 80 90 of the volume can be eroded depending on the way the generics come in if there's any ones i have six months exclusivity then they don't drop the price that much but in the end pretty much the business goes away, which is great because that's what pharma companies should do.

28:10They get their phenomenal dollars behind the R &D, make a new drug, make a lot of profit for 10 years, 11 years, eight years, whatever the length of time is. Then everybody gets access to it at a much lower price. And Merck is the same because they've got Keytruda coming up. So both of these companies are looking ahead to this issue. Both are, therefore, stories about pipeline. What have I got to replace this lost sales. Merck's hole is potentially bigger, at least just basing that on the volume of sales today or value of sales today. But yet, when you look at, I've just done the chart here, I was looking at it and playing with it now.

28:47You look at Merck, it's up 60 % in 12 months, 60%. That's pretty much not far from where the S &P 500 is. Pfizer is up 7%, so massive underperformance. Why? Because one has been able to convince that they've got the pipeline, the other one hasn't. So, Sam, is the number of drugs and the amount of sales associated with those drugs potentially at risk or scheduled to come off patent? Is it more today than it's been in the past? It just seems like we hear about it more and more from these big companies. Well, yes and no, because we've had these big patents, the biggest patent cliff was around the 2010 timeframe where Pfizer themselves went and bought Shearing Plough.

29:34If I'm not mistaken, it's a long time ago. One is allowed a little bit of memory. I think it was Shearing Plough and then bought another company. Anyway, they did these mega mergers. Remember the one we were talking about yesterday with what Astra is doing, which is why I'm incredulous because they don't have a patent expiry issue to deal with. Anyway, remember the drugs are bigger now. The sales are bigger now. So when you have a Keytruda that I don't think anyone, you go back and use our MODL function and have a look and see what people thought Keytruda would be selling, which is a cancer drug by Merck, back in 2016, 17, maybe$10 billion.

30:14The thing is heading for$40 billion of sales because it turned into a pipeline of product. That is a big number. Imagine our GLP wants for Lilly one day when Monjaro goes off patent or whatever. How do you deal with a$30,$40 million sales implosion? That is tougher, which is why they're talking about it more and investors are, if you want, more focused on it.

30:40Scarlet Fu:Right. Makes a lot of sense. Before we let you go, just a quick question on BioNTech. This is, of course, a German drugmaker, and it's still talking about a COVID-19 vaccine, demand shrinking for that. And what does demand for a COVID-19 vaccine look like right now? I mean, certainly in the U.S., it kind of has dropped off the conversation completely. Yeah, I mean, so people still taking it. I mean, what's happening with COVID, which is very interesting, is that we've had four years since the pandemic, we've had two waves. This year, the summer waves have disappeared. which seems to be heading, if this sticks, to a winter wave, which is what other coronaviruses and most cold viruses seem to have.

31:23So this would mean that if there was any demand for the summer period, that's fallen by the wayside. And they just downgraded their guidance by about 10 % for the full year. But Moderna has been sticking with this guidance. So some competition going on there, I think.

31:39Scarlet Fu:This is the Bloomberg Intelligence Podcast, available on Apple, Spotify, and anywhere else you get your podcasts. Listen live each weekday, 10 a.m. to noon Eastern on Bloomberg.com, the iHeartRadio app, TuneIn, and the Bloomberg Business app. You can also watch us live every weekday on YouTube and always on the Bloomberg Terminal.

32:05Scarlet Fu:Healthcare doesn't always work great. If you've ever waited on a refill or couldn't schedule an appointment, you get it. That's the kind of stuff Optum is changing. They're using data and technology to integrate patient care, pharmacy, and everything else. So healthcare is connected, not complicated. What's that look like? Cheaper prescriptions that are easier to get and care that looks at the whole person. How you need it. Optum is helping make healthcare work as one for everyone. Learn more at business.optum.com. everyone's talking about how ai is transforming work especially in sales while the landscape shifts one thing remains the same the thrill of closing a deal whether it's a gong or a confetti machine every team has its celebration rituals adio is designed for that moment it's the agentic crm that turns customer signals into actionable insights helping you close deals faster with revenue agents and automations working around the clock you'll have everything you need to scale your go-to market efforts.

33:01Elevate your wins with Adio. Start your free trial at adio.com slash iHeart.

33:07Scarlet Fu:There are exciting things happening at your local CVS. Shop new extra big deals with ExtraCare every two weeks. No coupon needed. Plus, get access to exclusive sale prices, personalized deals, and more as a member. ExtraCare is the way to save at CVS. Join for free online or in-store and start saving. Visit your local CVS store or cvs.com slash extra big deals for this week's deals.

From the publisher

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu 

-Mandeep Singh, Global Head of Tech Research for Bloomberg Intelligence, discusses top tech stories. Palantir Technologies Inc. shares jumped after the company boosted full-year revenue and income forecasts and described commercial demand for its data analytics tools as “otherworldly.” Separately, Anthropic has struck a deal for computing capacity from Volta Infra Holdings, a months-old infrastructure startup, to keep pace with demand for its products.

-Michael Halen, Bloomberg Intelligence Senior Restaurant and Foodservice Analyst, discusses McDonald's earnings. McDonald's named Skye Anderson as president of its US business to lead turnaround efforts after posting its slowest growth in over a year. Sales at established US restaurants rose 0.8% in the second quarter, partly offset by a decline in visits, and marketing programs didn't meet expectations.

-Christopher Ciolino, Bloomberg Intelligence Senior US Machinery Analyst, recaps Carterpillar earnings. Caterpillar reported stronger sales across its businesses and raised its sales outlook, easing concerns that demand for power-generation equipment was beginning to cool. The company's power and energy unit has grown to become its largest by sales, driven by demand for generators, engines, and gas turbines for industrial facilities and large-scale computing centers.

Sam Fazeli, Bloomberg Intelligence, Director of Research: Healthcare, Defence, Industrials & Auto, discusses the latest in the biotech sector. Pfizer raised the midpoint of its 2026 sales forecast after reporting strong second-quarter demand for older medicines, with sales for the year expected to be $60.5 billion to $62.5 billion. Merck & Co. boosted its 2026 sales outlook after strong demand for newer drugs like Winrevair helped to drive revenues higher in the second quarter. BioNTech SE lowered its revenue outlook as demand for its Covid-19 vaccine shrank more than expected.

See omnystudio.com/listener for privacy information.

More from Bloomberg Intelligence

All 414 episodes
Palantir Jumps After ‘Otherworldly Demand Lifts OutlookBloomberg Intelligence · 22 min
Listen in VO